Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 94Neoplasm Metastasis 9Prostatic Neoplasms, Castration-Resistant 5Breast Neoplasms 3Neoplasms 2Metastatic Castration Resistant Prostate Cancer 2Castration-resistant Prostate Cancer 2Urinary Bladder Neoplasms 1Stage II Prostate Adenocarcinoma 1Salivary Glands Tumors 1Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1Pharmacogenetic Study 1Oligometastatic Prostate Carcinoma 1Neoadjuvant Therapy 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone Refractory Prostate Cancer 1Metastatic Castration-resistent Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Dementia 1Cushing Syndrome 1Cognitive Dysfunction 1Castrate-resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Cancer Pain 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

Docetaxel 4enzalutamide 3darolutamide 3cabazitaxel 3Pluvicto 3testosterone 17 beta-cypionate 2radium Ra 223 dichloride 2Nivolumab 2sipuleucel-T 1rucaparib 1poly ICLC 1pamiparib 1lactitol 1fludarabine phosphate 1fludarabine 1fluciclovine F-18 1enfortumab vedotin 1ebastine 1copanlisib 1cabozantinib 1bempegaldesleukin 1avelumab 1alovudine 1abiraterone 1Standard of Care 1Single Photon Emission Computed Tomography Computed Tomography 1Selegiline 1Radium-223 1Radiosurgery 1Radionuclide Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metastatic Castration-resistant Prostate Cancer × Abiraterone Acetate × Clear all
NCT04879589 2023-04-28

Phase 1 Study of ATRS-2002 in Healthy Male Adults

Syneos Health

Phase 1 Withdrawn
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡